Skip to content

K-Stock Briefing

https://kstockbriefing.com

  • About Us
  • News
    • News
  • IR Room
  • RESEARCH
  • Disclosures
    • Semiconductors
    • Bio & Healthcare
    • Defense
    • Shipbuilding
  • Toggle search form

[Disclosure] Hanwha Aerospace (012450) Resolves on Year-end Cash Dividend for 48th Fiscal Year… KRW 3,500 Per Common Share, Total Payout of Approx. KRW 159.1B

Posted on February 24, 2025July 20, 2026 By K-STOCK Editor No Comments on [Disclosure] Hanwha Aerospace (012450) Resolves on Year-end Cash Dividend for 48th Fiscal Year… KRW 3,500 Per Common Share, Total Payout of Approx. KRW 159.1B

Source Fact: Financial Supervisory Service Electronic Disclosure System (DART) / 2025-02-24

Disclosure Type: Decision on Cash/In-kind Dividend

💡 3-Second Summary

Hanwha Aerospace has resolved on a year-end cash dividend of KRW 3,500 per common share for the 48th fiscal year, totaling KRW 159,132,918,000 with a dividend yield of 1.1%.

📊 1. [Summary of Core Disclosure Content and Key Figures]

  • Basic Dividend Specifications:
    • Dividend Category: Year-end dividend
    • Dividend Type: Cash dividend (No in-kind assets)
    • Disproportionate Dividend Allocation: No (Not applicable)
  • Dividend Per Share & Total Scale:
    • Dividend per Share: KRW 3,500 for common shares (None for preferred shares)
    • Dividend Yield: 1.1% for common shares
    • Total Dividend Amount: KRW 159,132,918,000
  • Record Date & Scheduled Timeline:
    • Record Date: 2024-12-31
    • Scheduled Dividend Payment Date: – (Left blank in the official text; payable within one month from the general meeting date)
    • Scheduled General Shareholders’ Meeting Date: 2025-03-25
  • Board Resolution & Share Count Details:
    • Board Resolution Date: 2025-02-24 (4 outside directors attended, 0 absent)
    • Share Count for Total Payout Calculation: 45,466,548 shares (Excluding 114,613 treasury shares held by the company)
  • Administrative Notes:
    • The dividend terms are subject to potential modification during the independent audit completion or the formal approval process at the Annual General Shareholders’ Meeting.
    • The dividend yield represents the ratio of the dividend per share to the arithmetic mean of the closing prices on the KRX over a one-week window ending two trading days prior to the record date.

📈 2. [Expert Perspective: What This Disclosure Means for Investors]

This regulatory filing outlines the capital allocation parameters for shareholder returns decided by Hanwha Aerospace’s board for the 2024 fiscal year. With the baseline consideration fixed at KRW 3,500 per share, a total cash volume of approximately KRW 159.1B is allocated for distribution based on 45,466,548 outstanding shares, excluding the 114,613 treasury shares held in corporate account. The reported 1.1% yield serves as a factual marker of near-term return efficiency relative to the historical equity pricing structure defined in the administrative index.

Because this filing represents the initial board-level resolution, the stated figures are not definitively finalized. Investors must note the guiding provisos indicating that these metrics remain subject to modifications based on subsequent independent audit disclosures or voting outcomes at the upcoming Annual General Shareholders’ Meeting scheduled for March 25, 2025. While the administrative field for the exact payment date remains blank, the structural timeline is bound by Article 464-2 of the Commercial Act, mandating distribution within one month of shareholder adoption. Consequently, market participants should evaluate this statement as a preliminary corporate framework and monitor downstream general meeting outcomes for definitive confirmation.

📝 Editor’s Comment (by K-STOCK Editor)

Hanwha Aerospace’s regulatory filing details the board’s proposed capital distribution parameters for the 48th fiscal year, establishing a baseline for shareholder return metrics. The specific values of KRW 3,500 per share, the total aggregate payout of KRW 159,132,918,000, and the dividend yield index of 1.1% constitute the core factual variables delivered in this public notification.

From an analytical standpoint, the primary variable for market participants to track is whether this dividend proposal will be adopted without amendments during the scheduled general meeting on March 25, 2025. As explicitly communicated in the administrative notes of the official text, these figures are vulnerable to prospective calibration during the auditing finalization or the subsequent shareholder vote, and must not be treated as immutable metrics at this stage.

What to watch next includes tracking the formal voting outcomes of the general meeting to verify the unamended approval of this dividend allocation and confirming the definitive distribution schedule established post-adoption.

📢 Disclaimer & Source Information

Source: This content has been structured and newly written based on the official data submitted to the Electronic Disclosure System (DART) of the Financial Supervisory Service.

Investment Risk Notice: This content is provided solely for informational and linguistic reference purposes. Under no circumstances does it constitute financial advice or a recommendation to buy or sell specific stocks. All investment decisions and financial responsibilities rest entirely with the investor.

Inquiries: For compliance-related inquiries or copyright requests, please contact ksb220805@gmail.com.

Search by
Company Name or Stock Ticker.
Disclosures, Defense

Post navigation

Previous Post: [Disclosure] Jeju Semiconductor (080220) Amends $6B KRW Private CB Terms: Payment Postponed by 2 Days Due to Physical Certificate Shift
Next Post: [Disclosure] Hanwha Aerospace (012450) Resolves to Convene 48th Annual General Shareholders’ Meeting… Agenda Includes Reappointment of CEO Kim Dong-kwan and New Nomination of Former U.S. Deputy Assistant Secretary of Defense Michael Coulter

Related Posts

[Disclosure] Hanwha Aerospace (012450) Clarifies Media Report on Transferring Defense Functions to Hanwha Engine as Groundless Disclosures
[Disclosure] Alteogen(196170) Signs KRW 419.7B Exclusive License Agreement with Daiichi Sankyo for Human Hyaluronidase Technology (ALT-B4) Disclosures
[Disclosure] Samsung Biologics(207940) to Host Online IR Meeting for Retail Investors on Corporate Split on May 29 Disclosures
[Disclosure] PSK Holdings (031980) Designated as Investment Warning Stock After 200% Surge in 1 Year Semiconductors
[Disclosure] Hanwha Ocean (042660) Formally Announces Executive Leadership Update with Appointment of New CEO Hee-Cheul Kim Disclosures
[Disclosure] Celltrion (068270), Secures FDA Phase 3 Clinical Trial Application Approval for CT-P13 SC (Zymfentra) in Rheumatoid Arthritis Patients Disclosures

Leave a Reply Cancel reply

You must be logged in to post a comment.

  • [Disclosure] Alteogen (196170) Establishes August 6 as Record Date for Bonus Issue Share AllotmentJuly 16, 2026
  • [Disclosure] Alteogen (196170) Announces Trading Suspension and Resumption Schedule for Stock Futures and OptionsJuly 16, 2026
  • [Disclosure] Alteogen (196170) Temporarily Suspends Plans for Relisting on the KOSPI MarketJuly 16, 2026
  • [Disclosure] Alteogen (196170) Announces Temporary Trading Suspension on July 16 Due to Bonus Issue DecisionJuly 16, 2026
  • [Disclosure] Alteogen (196170) Decides on Bonus Issue of 0.3 Shares per 1 Common and Preferred ShareJuly 16, 2026

Copyright © 2026 K-Stock Briefing.

Powered by PressBook Grid Dark theme